Browse > Article

Synchronized Synergism Using Ethanol, L-lysine and $NaBH_4$ Glutaraldehyde Treated Porcine Pericardium  

Kim, Kwan-Chang (Department of Thoracic and Cardiovascular Surgery, Ewha Womans University School of Medicine)
Kim, Yong-Jin (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National College of Medicine)
Kim, Soo-Hwan (Seoul National University Hospital Clinical Research Institute, Xenotransplantational Research Center)
Choi, Seung-Hwa (Seoul National University Hospital Clinical Research Institute, Xenotransplantational Research Center)
Publication Information
Journal of Chest Surgery / v.42, no.6, 2009 , pp. 685-695 More about this Journal
Abstract
Background: Calcification is the most frequent cause of clinical failure of bioprosthetic tissues that are fabricated from Glutaraldehyde (GA)-fixed porcine valve or bovine pericardium. We recently used a multi-factorial approach of employing different mechanisms to investigate how to reduce the calcification of bioprosthetic tissues. The purpose of the present study was to evaluate the synchronized synergism using ethanol, L-lysine and $NaBH_4$ in glutaraldehyde treated porcine pericardium from the standpoint of calcification and tissue elasticity. Material and Method: Porcine pericardium was fixed with 0.625% GA (commercial fixation). An interim step of ethanol (80%; 1 day at room temperature) or L-lysine (0.1 M; 2 days at $37^{\circ}C$) or $NaBH_4$ (0.1 M; 2 days at room temperature) was followed by completion of the GA fixation (2 days at $4^{\circ}C$ and 7 days at room temperature). The tensile strength and thickness of the samples were measured. The treated pericardiums were implanted subcutaneously into three-week old Sprague-Dawley rats for 8 weeks. The calcium content was assessed by atomic absorption spectroscopy and the histology of the samples. Result: The amount of calcium in the pericardium pretreated with ethanol (13.6${\pm}$10.0 ug/mg, p=0.008), L-lysine (15.3${\pm}$1.0 ug/mg, p=0.002) and both (16.1${\pm}$11.1 ug/mg, p=0.012) was significantly reduced compared with the control (51.2${\pm}$8.5 ug/mg). However, $NaBH_4$ pretreatment (65.7${\pm}$61.8 ug/mg, p=0.653) and combined pretreatment that including ethanol, L-lysine and $NaBH_4$ (92.9${\pm}$58.3 ug/mg, p=0.288) were not significantly different from the controls(51.2${\pm}$8.5 ug/mg). Both the combined pretreatment using ethanol and L-lysine (7.60${\pm}$1.55, p=0.76) and the combined pretreatment that included ethanol, L-lysine and $NaBH_4$ (7.47${\pm}$1.85, p=0.33) increased the tensile strength/thickness ratio compared with that of the controls (4.75${\pm}$1.88). Conclusion: The combined pretreatment using ethanol and L-lysine seemed to decrease the calcification of porcine pericardium fixed with glutaraldehyde, as compared to single pretreatment, and it increase the tissue elasticity, but to the degree that showed synchronized synergism. $NaBH_4$ pretreatment seemed to increase the calcification of porcine pericardium, irrespective of whether single or combined pretreatment was used.
Keywords
Calcification; Bioprosthesis; Xenograft;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Grunkemeier GL, Jamieson WRE, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovas Surg 1994;108:709-18   PUBMED
2 Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1993;113:143-55
3 Jorge-Herrero E, Fernandez P, Gutierrez M, Castillo-Olivares JL. Study of the calcification of bovine pericardium: analysis of the implication of lipids and proteoglycans. Biomaterials 1991;12:638-89   DOI   ScienceOn
4 Thomas PJ, James AB, Barbara LC, Frederick JS, Gordon A, Robert JL. Controlled release of ethanehydroxy diphosphonate from polyurethane reservoirs to inhibit calcification of bovine pericardium used in bioprosthetic heart valves. Int J Pharm 1990;59:95-104   DOI   ScienceOn
5 Hirsch D, Drader J, Yhomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993;27:1477-84   DOI   ScienceOn
6 Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994;15:465-9   DOI   PUBMED   ScienceOn
7 Ameli E, Yates T, Hymana P, Zilla P. Detoxication on top of enhanced, diamine-etended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in sheep model. J Heart Valve Disease 2003;12:93-101
8 Eybl E, Grimm M, Grabenwoger M, Bock P, Muller M, Wolner E. Endothelial cell lining of bioprosthetic heart valve materials. J Thorac Cardiovasc Surg 1992;104:763-9   DOI   PUBMED   ScienceOn
9 Jee KS, Kim YS, Park KD, Kim YH. A novel chemical modification of bioprosthetic tissues using L-arginine. Biomaterials 2003;24:3409-16   DOI   ScienceOn
10 Maranto A, Schoen F. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valves. Circ Res 1988;63:844-8   DOI   PUBMED
11 Connolyy JM, Alferiev I, Kronsteiner A, Lu Z, Robert J. Levy ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride. J Heart Valve Disease 2004;13:487-93
12 Grabenwoger M, Grimm M, Eybl E, Leukauf C, Plenck H Jr, Bock P. Decreased tissue reaction to bioprosthetic heart valve material after L-giutamic acid treatment. A morphological study. J Biomed Mater Res 1992;26:1231-40   DOI   PUBMED
13 Moritz A, Grimm M, Eybl E, et al. Improved spontaneous endothelialization by postfixation treatment of bovine pericardium. Eur J Cardiothorac Surg 1991;5:155-60   DOI   ScienceOn
14 Humana P, Bezuidenhouta D, Torriannib M, Hendriksc M, Zilla P. Optimization of diamine bridges in glutaraldehyde treated bioprosthetic aortic wall tissue. Biomaterials 2002; 23:2099-103   DOI   ScienceOn
15 Neethling WM, Hodge AJ, Clode P, Glancy R. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium. J Cardiovasc Surg (Torino) 2006;47: 711-8
16 Zilla P, Weissenstein C, Bracher M, et al. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue. J Heart Valve Dis 1997;6: 502-9
17 Paul H, Peter Z. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001;71:S385   DOI   ScienceOn
18 Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model: pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations. Am J Pathol 1992;141:487-96
19 Chen W, Scheon FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-9   DOI   PUBMED
20 Kim KC, Choi YK, Kim SH, et al. Effect of diamine bridges using l-lysine in glutaraldehyde treated porcine pericardium. Korean J Thorac Cardiovasc Surg 2009;42:157-64
21 Kim KC, Lee C, Choi CH, et al. Development of porcine pericardial heterograft for clinical application (tensile strength-thickness). Korean J Thorac Cardiovasc Surg 2008; 41:170-6
22 Jorge-Herrero E, Fernandez P, Escudero C, Garcia-Paez JM, Castillo-Olivares JL. Calcification of pericardial tissue pretreated with different amino acids. Biomaterials 1996;17: 571-5   DOI   ScienceOn
23 Nimni WN, Cheung D, Strates B. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1994;15:465-9   DOI   ScienceOn
24 Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinkingmethods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 1990;24:345-61   DOI   PUBMED
25 Lee CH, Vyavahare N, Zand R, et al. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42:30-7   DOI   ScienceOn
26 Schoen FJ, Levy RJ, Piehler HR. Pathological considerations in replacement cardiac valves. Cardiovase Pathol 1992;1:29-52   DOI   ScienceOn
27 Quesenberry MS, Lee YC. A rapid formaldehyde assay using purpald reagent: application under periodation conditions. Anal Biochem 1996;234:50-5   DOI   ScienceOn
28 Moritz A, Grimm M, Eybl E, et al. Improved biocompatibility by post fixation treatment of aldehyde fixed bovine pericardium. Trans Am Sot Artif Intern Organs 1990;36: M300-3
29 Levy RJ, Qu X, Underwood T, Trachy J, Schoen FJ. Calcification of valved aortic allografts in rats: effects of age, crosslinking, inhibitors. J Biomed Mater Res 1995;29:217-26   DOI   ScienceOn
30 Garcia Paez JM, Jorge-Herrero E, Carrera A, et al. Chemical treatment and tissue selection: factors that influence the mechanical behaviour of porcine pericardium. Biomaterials 2001;22:2759-67   DOI   ScienceOn